EUVIMEDEUVIMED entdecken
Kontrollierte klinische Studie

The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial

Jing Yang, Weipeng Zhan, Zeping Zhang, Yuqi Ma, Hongwei Tian, Ming Hu, Xianbing Huang, Wutang Jing, Jin Guo, Yuan Deng, Wei Fang, Dongdong Chen und 5 weitere

Surgical Endoscopy · 2025-11 · 39 (11) · 7336-7346

DOI: 10.1007/s00464-025-12005-8 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Surgical Endoscopy, online erschienen am 28.08.2025. Verfasst von Jing Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Gansu Provincial Hospital, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Cholecystectomy, Laparoscopic, Wireless Technology, Cholecystectomy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China Regional Program, Gansu Provincial Natural Science Foundation Project, Science and Technology Plan (Joint Research Fund) Project of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Since advances in the fifth-generation (5G) communication technology have effectively facilitated the development of robotic telesurgery, the popularity of telerobotic operations has increased. The purpose of this study was to evaluate the safety and feasibility of robotic telecholecystectomy with a 5G wireless network using a new domestic robotic surgical system. METHODS: This study is a prospective controlled clinical trial. From 2023, our center conducted two independent prospective clinical trials using the Toumai® laparoscopic surgical robot. The 5G remote robotic cholecystectomy clinical trial was conducted from May to August 2023 and included a total of 20 patients in the remote group. The local robotic general surgical trial was conducted from June 2023 to October 2023 and included a total of 20 patients undergoing cholecystectomy in the local group. The surgical success rate (intraoperative and within 24 h postoperatively) was the primary endpoint, and the docking time, console time, intraoperative blood loss, complications, postoperative hospitalization days, delay time in the network, and packet loss were used as the secondary endpoints. RESULTS: The surgical success rates in the two groups were 95 and 100%. Compared with the local group, the remote group had a significantly shorter docking time (7.6 ± 2.5 vs. 9.9 ± 3.4 min, p = 0.02). No statistical differences in console time, intraoperative blood loss, and hospitalization time were observed (p > 0.05). The 5G communication network remained stable throughout all procedures, with consistent metrics for latency, jitter, and bandwidth as monitored by the technical team. The communication environment was stable, and the average network delay time was 43.4 ms, network jitter was 4 ms, the upload rate was 98.3 Mbps, the download rate was 213 Mbps, and packet loss < 1% as monitored by the clinical engineers. CONCLUSIONS: Robotic telecholecystectomy based on 5G communication technology can be performed with a level of safety and efficacy comparable to that of local robotic surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresCholecystectomy, LaparoscopicWireless TechnologyCholecystectomyHumansFeasibility StudiesFemaleMaleProspective StudiesMiddle AgedAdultOperative TimeTelemedicineAgedTreatment OutcomePostoperative ComplicationsLength of Stay

Stichwörter der Autor:innen

5G communication technologyLaparoscopic surgical robotRobotic telesurgeryTelecholecystectomy

Autor:innen und Institutionen

  • Department of General Surgery, Gansu Provincial Hospital, Lanzhou, 730000, China.
  • NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor & Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, Lanzhou, 730000,…
  • First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, 730000, China.
  • Department of General Surgery, Gansu Provincial Hospital, Lanzhou, 730000, China. 3575515665@qq.com.
  • Gansu Provincial Hospital, Lanzhou, 730000, China. caialonteam@163.com.

Förderung

  • National Natural Science Foundation of China Regional Program
  • Gansu Provincial Natural Science Foundation Project
  • Science and Technology Plan (Joint Research Fund) Project of Gansu Province
  • Gansu Province Longyuan Talent Project

Zitieren

APA

Yang, J., Zhan, W., Zhang, Z., Ma, Y., Tian, H., Hu, M., Huang, X., Jing, W., Guo, J., Deng, Y., Fang, W., Chen, D., Miao, C., Ma, S., Zhang, W., Ma, Y., & Cai, H. (2025). The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial. Surgical Endoscopy, 39(11), 7336-7346. https://doi.org/10.1007/s00464-025-12005-8

Vancouver

Yang J, Zhan W, Zhang Z, Ma Y, Tian H, Hu M, et al. The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial. Surgical Endoscopy. 2025;39(11):7336-7346. doi:10.1007/s00464-025-12005-8

BibTeX
@article{Yang2025,
  author = {Yang, Jing and Zhan, Weipeng and Zhang, Zeping and Ma, Yuqi and Tian, Hongwei and Hu, Ming and Huang, Xianbing and Jing, Wutang and Guo, Jin and Deng, Yuan and Fang, Wei and Chen, Dongdong and Miao, Changfeng and Ma, Shixun and Zhang, Wentao and Ma, Yuntao and Cai, Hui},
  title = {The safety and feasibility of telerobotic cholecystectomy via a 5G network: a prospective controlled clinical trial},
  journal = {Surgical Endoscopy},
  year = {2025},
  volume = {39},
  number = {11},
  pages = {7336--7346},
  doi = {10.1007/s00464-025-12005-8}
}
Kostenlos starten →